[Parieval in 52 cases of internal ear deafness].
D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003638:Deafness / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007759:Labyrinth Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000031:analogs & derivatives*; D014748:Vinca Alkaloids / Q000627:therapeutic use*; D014749:Vincamine / Q000627:therapeutic use*; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000627:therapeutic use
D002317:Cardiovascular Agents; D004338:Drug Combinations; D006896:Hydroxyethylrutoside; D014748:Vinca Alkaloids; D014810:Vitamin E; D012431:Rutin; C030770:parieval; D014749:Vincamine
Etude du parieval dans 52 cas de surdité d'orielle interne.